comparemela.com

Page 8 - Orca Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rick Klausner s potential cell therapy breakthrough, Lyell Immunopharma, files for $150M IPO

Rick Klausner s potential cell therapy breakthrough, Lyell Immunopharma, files for $150M IPO
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO

(Nasdaq) Preclinical biotech Lyell Immunopharma is looking to go public after a whirlwind year of big deals and big bucks raises as it looks to use cell therapy to beat solid tumors. Lyell is certainly not short on cash, having banked $493 million in what was the second-largest private funding round for biotechs in 2020. That raise came five months after the company inked a five-year deal with GlaxoSmithKline to boost the “fitness” of T cells in the latter’s cell therapy programs. The duo hopes to improve the efficacy of T-cell therapies in solid tumors and prevent relapses stemming from T-cell exhaustion.

Digital Experience Platform Raydiant Raises $13M Series A Co-Led by 8VC and Atomic with Backing from Mark Wahlberg

Raydiant Raydiant was founded in 2017 to create connected experiences for brick-and-mortar businesses of any size, from small cafes to global enterprises, with its cloud-based digital signage technology. By plugging in a Raydiant ScreenRay into any HDMI-equipped TV, businesses can create messages for in-store customers ranging from check-in procedures, sales and promotions to live video support, photos and social media feeds. Raydiant s customers see an average revenue increase of 12% along with more repeat customers, and stronger brand loyalty. The pandemic significantly accelerated Raydiant s growth as retailers and restaurants used Raydiant to provide information about safety protocols, new store hours and takeout options. The brands who survive and thrive in the years ahead will be those who focus on serving these consumers and use in-location experiences as a competitive advantage.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.